IECM
Intrinsic Edge Capital Management’s DexCom DXCM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-24,591
| Closed | -$2.79M | – | 113 |
|
2024
Q2 | $2.79M | Sell |
24,591
-16,506
| -40% | -$1.87M | 0.25% | 104 |
|
2024
Q1 | $5.7M | Buy |
+41,097
| New | +$5.7M | 0.45% | 69 |
|
2023
Q4 | – | Sell |
-60,854
| Closed | -$5.68M | – | 116 |
|
2023
Q3 | $5.68M | Buy |
60,854
+30,000
| +97% | +$2.8M | 0.64% | 59 |
|
2023
Q2 | $3.97M | Hold |
30,854
| – | – | 0.28% | 103 |
|
2023
Q1 | $3.58M | Sell |
30,854
-68,167
| -69% | -$7.92M | 0.36% | 95 |
|
2022
Q4 | $11.2M | Sell |
99,021
-19,219
| -16% | -$2.18M | 1.12% | 29 |
|
2022
Q3 | $9.52M | Buy |
118,240
+60,000
| +103% | +$4.83M | 1.04% | 36 |
|
2022
Q2 | $4.34M | Buy |
58,240
+43,680
| +300% | +$3.26M | 0.34% | 86 |
|
2022
Q1 | $7.45M | Hold |
14,560
| – | – | 0.57% | 68 |
|
2021
Q4 | $7.82M | Sell |
14,560
-1,735
| -11% | -$932K | 0.5% | 62 |
|
2021
Q3 | $8.91M | Sell |
16,295
-17,590
| -52% | -$9.62M | 0.62% | 60 |
|
2021
Q2 | $14.5M | Buy |
33,885
+18,607
| +122% | +$7.95M | 0.85% | 25 |
|
2021
Q1 | $5.49M | Sell |
15,278
-25,046
| -62% | -$9M | 0.37% | 94 |
|
2020
Q4 | $14.9M | Buy |
40,324
+22,885
| +131% | +$8.46M | 1.1% | 19 |
|
2020
Q3 | $7.19M | Buy |
17,439
+7,704
| +79% | +$3.18M | 0.49% | 70 |
|
2020
Q2 | $3.95M | Sell |
9,735
-19,260
| -66% | -$7.81M | 0.36% | 100 |
|
2020
Q1 | $7.81M | Buy |
+28,995
| New | +$7.81M | 1.03% | 28 |
|